ALL N = 38 | [ART + C] N = 21 | [ART Alone] N = 17 | P Value* | |
---|---|---|---|---|
Demographics | ||||
Gender (female), n[%] | 25 [65.8%] | 14 [66.7%] | 11 [64.7%] | 0.899a |
Age (years) median IQR | 33 [2;39] | 36 [27;42] | 28 [25;34] | 0.050b |
Clinical parameters | ||||
Systolic BP (mmHg) median [IQR] | 118 [110;125] | 118 [110;125] | 118 [110;121] | 0.668b |
Diastolic BP (mmHg median [IQR] | 77 [71;83] | 76 [65;80] | 77 [71;84] | 0.561b |
Diabetes; n [%} | 1 [2.6%] | 1 [4.8%] | 0 | 1.000a |
Hypertension, n [%} | 7 [18.4%] | 5 [23.8%] | 2 [11.8%] | 0.306a |
Tuberculosis at baseline, n [%} | 10 [26.3] | 7 [33.3%] | 3 [17.6%] | 0.242a |
Commenced on ACE/ARB; n [%} | 27 [71.1%] | 14 [66.7%] | 12 [70.6%] | 0.519a |
ART regimen at baseline, n [%} | 0.332a | |||
- D4T/3TC/EFV or NEV | 20 [52.6%] | 11 [52.4%] | 9 [52.9%] | |
- ABC/3TC/EFV or NEV | 9 [23.7%] | 7 [33.3%] | 2 [11.8%] | |
- ZVD/3TC/EFV or NEV | 6 [15.8%] | 2 [9.5%] | 4 [23.5%] | |
- Other/unknown | 3 [7.9%] | 1 [4.8%] | 2 [11.8%] | |
Biochemical parameters | ||||
eGFR (ml/min/1.73m2) median[IQR] | 43.5 [26;70] | 35 [18;46] | 47 [39;97] | 0.015b |
eGFR (ml/min/1.73m2) mean [SD] | 50 [32.8] | 37.8 [26.0] | 65.1 [34.8] | |
CD4 (cells/mm3) median[IQR] | 158 [63;309] | 158 [36;272] | 173 [104;352] | 0.437b |
HIV VL (Log 10) (cps/ml) median[IQR] | 4.77 [3.87;5.29] | 4.77 [4.5;5.29] | 4.69 [2.75;5.3] | 0.5623b |
Albumin (g/L) median[IQR] | 30 [25;33] | 29 [24;32] | 30.5 [27;36] | 0.262b |
uPCR (g/mmol) median[IQR] | 0.36 [0.14;0.54] | 0.43 [0.17;0.52] | 0.23 [0.13;0.60] | 0.617b |
Haemoglobin (g/dL) median[IQR] | 8.1 [7.3;10.2] | 8.0 [7.4;9.9] | 8.1 [7.3;10.2] | 0.872b |
Cholesterol(mmol/l) median[IQR] | 4.5 [3.6;5.6] | 4.4 [3.3;5.1] | 4.8 [3.9;6.0] | 0.347b |